Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
25.69
-0.32 (-1.23%)
Apr 24, 2026, 2:48 PM EDT - Market open
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $1.42 billion as of April 24, 2026. Its market cap has increased by 328.11% in one year.
Market Cap
1.42B
Enterprise Value
1.09B
1-Year Change
328.11%
Ranking
Category
Stock Price
$25.69
Market Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $1.42B, an increase of 107.13%. That is a compound annual growth rate of 81.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 1.44B | -27.92% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.54B |
| Bicara Therapeutics | 1.50B |
| Immunocore Holdings | 1.50B |
| AnaptysBio | 1.49B |
| Immatics | 1.49B |
| Viridian Therapeutics | 1.46B |
| Ardelyx | 1.45B |
| Iovance Biotherapeutics | 1.41B |